These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 8172740)

  • 1. MR imaging of the pancreas at 0.3 T using a super-paramagnetic oral contrast medium.
    Wallengren NO; Holtås S; Andrén-Sandberg A; Bach-Gansmo T
    Acta Radiol; 1994 Mar; 35(2):147-51. PubMed ID: 8172740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superparamagnetic particles as oral contrast medium in MR imaging of malignant lymphoma.
    Lönnemark M; Hemmingsson A; Bach-Gansmo T; Hagberg H; Magnusson A; Gundersen HG; Nyman R
    Acta Radiol; 1991 May; 32(3):232-8. PubMed ID: 2064867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR enteroclysis using iron oxide particles (ferristene) as an endoluminal contrast agent: an open phase III trial.
    Boraschi P; Braccini G; Gigoni R; Cartei F; Perri G
    Magn Reson Imaging; 2004 Oct; 22(8):1085-95. PubMed ID: 15527995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral magnetic particles as a contrast agent for MR imaging of the abdomen. A phase III clinical trial.
    Vlahos L; Gouliamos A; Kalovidouris A; Athanasopoulou A; Kotoulas G; Lygidakis N; Liaou A; Matsaidonis D; Papavasiliou C
    Hepatogastroenterology; 1994 Feb; 41(1):82-5. PubMed ID: 8175124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral superparamagnetic particles for magnetic resonance imaging. Effect in plain and viscous aqueous suspensions.
    Lönnemark M; Hemmingsson A; Ericsson A; Gundersen HG; Bach-Gansmo T
    Acta Radiol; 1990 May; 31(3):303-7. PubMed ID: 2386643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of Abdoscan in MRI cholangio-pancreatography and MRI urography].
    Lecesne R; Drouillard J; Cissé R; Schiratti M
    J Radiol; 1998 Jun; 79(6):573-5. PubMed ID: 9757288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
    Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
    Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nuclear magnetic resonance tomography of the pelvis: rectal administration of a new super-paramagnetic contrast medium].
    Kersting-Sommerhoff B; Allgayer B; Western A; Gerhardt P
    Rontgenpraxis; 1995 Dec; 48(12):353-6. PubMed ID: 8584960
    [No Abstract]   [Full Text] [Related]  

  • 9. MR cholangiopancreatography diagnosis of juxtapapillary duodenal diverticulum simulating a cystic lesion of the pancreas: usefulness of an oral negative contrast agent.
    Mazziotti S; Costa C; Ascenti G; Gaeta M; Pandolfo A; Blandino A
    AJR Am J Roentgenol; 2005 Aug; 185(2):432-5. PubMed ID: 16037516
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quality rating of MR-cholangiopancreatography with oral application of iron oxide particles].
    Lorenzen M; Wedegärtner U; Fiehler J; Adam G
    Rofo; 2003 Jul; 175(7):936-41. PubMed ID: 12847648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospective study to compare high-resolution computed tomography and magnetic resonance imaging in the detection of pancreatic neoplasms: use of intravenous and oral MR contrast media].
    Fink C; Grenacher L; Hansmann HJ; Düx M; Leipold R; Spielhaupter E; Kauffmann GW; Richter GM
    Rofo; 2001 Aug; 173(8):724-30. PubMed ID: 11570243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MR imaging of colonic cancer with retrograde administration of contrast material containing ferric ammonium citrate].
    Mizuguchi M; Matsuo Y; Fukahori T; Kudo S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1063-5. PubMed ID: 8587850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superparamagnetic particles as an oral contrast medium in abdominal magnetic resonance imaging.
    Lönnemark M
    Acta Radiol Suppl; 1992; 378 ( Pt 3)():109-21. PubMed ID: 1323193
    [No Abstract]   [Full Text] [Related]  

  • 14. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT.
    Hatanaka K; Kudo M; Minami Y; Maekawa K
    Oncology; 2008; 75 Suppl 1():42-7. PubMed ID: 19092271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral magnetic particles as an MR contrast medium for the gastrointestinal tract].
    Rinck PA; Myhr G; Smevik O; Børseth A
    Rofo; 1992 Dec; 157(6):533-8. PubMed ID: 1457787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time contrast-enhanced endoscopic ultrasonography-guided fine-needle aspiration (with video).
    Ueda K; Yamashita Y; Itonaga M
    Dig Endosc; 2013 Nov; 25(6):631. PubMed ID: 24112287
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral magnetic particles. Results from clinical phase II trials in 216 patients.
    Oksendal AN; Bach-Gansmo T; Jacobsen TF; Eide H; Andrew E
    Acta Radiol; 1993 Mar; 34(2):187-93. PubMed ID: 8452728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.
    Hahn PF; Stark DD; Lewis JM; Saini S; Elizondo G; Weissleder R; Fretz CJ; Ferrucci JT
    Radiology; 1990 Jun; 175(3):695-700. PubMed ID: 2343116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy.
    Kivelitz D; Gehl HB; Heuck A; Krahe T; Taupitz M; Lodemann KP; Hamm B
    Acta Radiol; 1999 Jul; 40(4):429-35. PubMed ID: 10394873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic fast-gradient echo MR imaging of pancreatic tumours.
    Tervahartiala P; Kivisaari L; Lamminen A; Maschek A; Wöhling H; Standertskjöld-Nordenstam CG
    Eur J Radiol; 1997 Jul; 25(1):74-80. PubMed ID: 9248804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.